Cambridge, MA – GC Therapeutics has announced the appointment of Stefan Irion as Chief Scientific Officer. About GC Therapeutics: GC Therapeutics (GCTx) is a pioneering biopharmaceutical company harnessing the worlds first plug-and-play induced pluripotent stem…
OREM, Utah–(BUSINESS WIRE)–Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today announced the completion of a $15 million capital raise led by Van Tuyl Companies, with participation from existing investors…
Led by Intrepid Growth Partners and GV (Google Ventures), funding advances Iterative Health’s position as the leading multispecialty clinical research network CAMBRIDGE, Mass.–(BUSINESS WIRE)–Iterative Health, a healthcare technology and services company powering the acceleration of…
LOS ANGELES–(BUSINESS WIRE)–Chance Studios Inc., the superapp empowering trading card game (TCG) collectors to collect, connect, and share their collections, has raised $3.2 million in its funding. The round was co-led by Makers Fund and…
Santa Clara, CA – ThreatDown has announced the appointment of Chung Ip as Chief Financial Officer. About ThreatDown: ThreatDown is an award-winning, all-in-one cybersecurity software platform designed for managed detection and response (MDR) and advanced…
Bay City, MI – PRO-SET Formulated Resin Systems has announced the appointment of Pete Hughes as President. About PRO-SET Formulated Resin Systems: PRO-SET Formulated Resin Systems LLC is a global platform focused on delivering high-performance…
Ambler, PA – Lansing Street Advisors has announced the appointment of Mike Horwath as Chief Investment Officer. About Lansing Street Advisors: Lansing Street Advisors is a full-service fiduciary wealth management firm based in Ambler, PA,…
NEW YORK–(BUSINESS WIRE)–Fun, the payments infrastructure company powering some of the largest internet-native capital markets, including Polymarket, today announced a $72 million Series A funding round. Co-led by Multicoin Capital and SignalFire, the funding comes…
Financing extension led by 8VC to advance LTS-201 as a potential significant commercial opportunity in Huntington’s disease (IND expected in 3Q 2026) Potential clinical proof-of-concept of Latus platform from LTS-101 in CLN2 disease expected in…
AI executes work across millions of files for operational excellence.Professional knowledge workers sign off. PALO ALTO, Calif.–(BUSINESS WIRE)–Nace.AI today announced it has raised $21.5 million in seed funding, led by Walden Catalyst with participation from General…